350
Participants
Start Date
November 30, 2023
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2027
Concurrent Chemoradiation, Systemic Chemotherapy other locally directed therapies (like surgery, ablation, etc.)
The aim is to include all patients with (induced) oligo metastatic and oligo recurrent settings, irrespective of whether treated with concurrent chemoradiation, systemic chemotherapy, or with other locally directed therapies (like surgery, ablation, etc.)
Lead Sponsor
Tata Memorial Centre
OTHER
Erasmus Medical Center
OTHER